Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2019 02:00 ET | Source: PledPharma AB

Aladotes® resultat är utvald för presentation på The International Liver Congress

Stockholm, 31 januari 2019. PledPharma AB (publ) meddelar att abstraktet med de positiva resultaten från Aladotes® Fas Ib/IIa proof of principle-studie har utvalts för muntlig presentation på den...
January 31, 2019 02:00 ET | Source: PledPharma AB

Aladote®’s data has been selected for presentation at The International Liver Congress

Stockholm, January 31, 2019. PledPharma AB (publ) announces that the abstract on the positive results from the Aladote®’s Phase Ib/IIa proof of principle-study has been selected for an oral...
December 13, 2018 02:00 ET | Source: PledPharma AB

PledPharma presenterar resultat från studie på läkemedelskandidaten Aladote® för paracetamolförgiftning på global toxikologikonferens

Stockholm, 13 december 2018. PledPharma AB (publ) meddelar att bolagets Aladote® fas Ib/IIa studieresultat har accepterats för presentation på den globala toxikologikonferensen ”58th Annual Meeting of...
December 13, 2018 02:00 ET | Source: PledPharma AB

PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference

Stockholm, December 13, 2018. PledPharma AB (publ) announces that the company's Aladote® Phase Ib/IIa study results has been accepted for a poster presentation during the “58th Annual Meeting of the...